All-cause mortality in post–myocardial infarction patients with reduced LVEF with and without ICD therapy: insights from the PROFID study
Previous randomized trials have demonstrated a survival benefit of implantable cardioverter-defibrillator (ICD) therapy in patients with reduced left ventricular ejection fraction (LVEF). However, advances in heart failure therapy and post–myocardial infarction (MI) management over the past decade may have modifi...